摘要
Marcellino POLTRONIERI 医师
颈面部整形外科医师
Modulation of the NAD⁺/Sirtuin pathway combined with dermal biostimulation using polynucleotides: a multilevel strategy for skin longevity
Objectives: To evaluate the clinical relevance and biological rationale of a dual‑level anti‑aging strategy combining systemic activation of the NAD⁺/sirtuin metabolic pathway with localized dermal biostimulation using polynucleotide injectables. The objective was to determine whether metabolic priming enhances fibroblast responsiveness and improves global skin quality outcomes.
Introduction: Skin aging results from mitochondrial decline, impaired DNA repair, ECM degradation and chronic inflammation. A key upstream driver is NAD⁺ depletion, which weakens sirtuin‑mediated genomic stability, mitochondrial function and oxidative stress control. Polynucleotides complement this pathway by activating A2A receptors, enhancing fibroblast activity, ECM synthesis and tissue hydration. Combining metabolic activation with dermal biostimulation may offer synergistic benefits for skin longevity.
Materials / method: Adults aged 35–65 with visible facial aging followed a 4–8‑week combined protocol: oral NAD⁺/sirtuin metabolic activation and 2–3 intradermal sessions with polynucleotide injectables. Outcomes included cutometry for elasticity, corneometry for hydration, and high‑frequency ultrasound for dermal density. Standardized photography and patient‑reported evaluations were collected as secondary measures.
Results: Three cases showed consistent improvement. Patient A reported +18% elasticity and +22% hydration, with reduced micro‑roughness and redness. Patient B showed a +15% increase in dermal density and better mandibular contour. Patient C demonstrated greater radiance, smoother texture and fewer fine lines. Metabolic activation appeared to prime fibroblasts, enhancing their response to polynucleotide‑driven ECM remodeling.
Conclusion: This integrated metabolic‑regenerative strategy represents a promising frontier in preventive aesthetic medicine. The combination of systemic NAD⁺/sirtuin pathway enhancement with polynucleotide‑based dermal biostimulation offers a biologically coherent, synergistic, and clinically meaningful approach to improving skin quality and promoting long‑term dermal longevity.
披露 - Marcellino POLTRONIERI
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 5月 21日 - Recorded during IMCAS Americas 2026